ArticleJournal of translational medicine2025

PYGO1 drives gastric cancer progression via the ITGB1/CD47 axis and is therapeutically targeted by pentagalloylglucose.

Yanjuan Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.